PharmD Info

A forum for Indian Pharmacy Professionals

Share any Pharmaceutical related news with appropriate reference. Latest Pharmaceutical News, Indian Pharma News,
  • User avatar
#1909
Stating that the ‘regulator is watching’, Union Health Secretary C.K. Mishra said the State drug inspectors were following standard procedures by enquiring into the quality of drugs being supplied in domestic markets.

The development comes after drug regulators in seven States across India sent notices to 18 pharmaceutical companies, saying that nearly 27 medicines manufactured by these companies had failed quality tests.

According to a report in a leading English daily, while the crackdown against substandard medicines has been under way since March this year, only one out of the 18 companies had recalled a substandard drug from the market and two had stopped distribution of batches of inferior quality drugs.

Regulator is watching

“We have asked for reports from the State drug regulators. The message is simple, the regulators are watching. This is routine procedure and we have been doing it from time to time,” said Mr Mishra. The drug regulators of Karnataka, West Bengal, Andhra Pradesh, Maharashtra, Gujarat, Kerala and Goa have pointed out various deficiencies with regards to labelling of the drugs and dosage etc.

Meanwhile, the report on nearly 48,000 drug samples surveyed as part of the National Drug Survey is expected to be tabled in the winter session of Parliament. The 400-page report covers the survey over two years by the National Institute of Biologicals (NIB) to gather evidence about the extent of spurious drugs in the Indian markets. This is the first pan-Indian survey, said Dr G.N. Singh, Drug Controller General of India who heads the Central Drug Standard Control Organization (CDSCO).

According to National Centre of Biotechnology Information (NCBI), in 2009, the Indian government sampled 24,136 drugs of 62 brands in a nationwide survey. “Samples were drawn from over 100 pharmacy outlets from various regions of India, which belonged to nine therapeutic categories of 30 manufacturers. Survey affirmed that only 11 products (0.046 per cent) were spurious,” stated the paper by A.N. Khan and R.K. Khar.

In the last few years, CDSCO has been cracking down on companies that make falsified/spurious or substandard drugs. According to the health ministry, 35, 35, 34 cases of substandard quality were reported during 2009-2010, 2010-2011 and 2011-2012, respectively.
Attachments:
The Pioneer.jpg
The Pioneer.jpg (1.15 MiB) Viewed 1789 times
The Hindu06.jpg
The Hindu06.jpg (1.36 MiB) Viewed 1789 times
The Hindu.jpg
The Hindu.jpg (1 MiB) Viewed 1789 times
Similar Topics
Topics Statistics Last post
0 Replies 
5445 Views
by Admin
02 Sep 2019, 19:12
0 Replies 
1359 Views
by Prajith
20 Jun 2016, 12:45
0 Replies 
1311 Views
by Admin
23 Feb 2017, 12:58
0 Replies 
817 Views
by Admin
17 Nov 2019, 16:29
0 Replies 
992 Views
by Admin
28 Apr 2020, 17:04

Medical editors are proactive member of the medica[…]

Dear all, NGSM Institute of Pharmaceutical Scienc[…]

It is a blessing to be a mother. The biggest happi[…]

Online Databases That A Medical Writer Can Rely Up[…]

E-Learn Portal